Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Oculis Operations Sàrl is managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners, meaning each examiner is currently handling a single matter. Despite the involvement of multiple examiners, the portfolio is concentrated within 1 distinct art unit.
HUANG, GIGI GEORGIANA is the busiest examiner for the company, with 1 pending office action. This accounts for a portion of the 2 total pending office actions. The focus within the distinct art unit suggests that while different examiners are involved, the subject matter of the actions falls under a single specialized group in the Biotechnology & Pharmaceuticals sector.
The distribution across the examiners ensures that the workload is shared. HUANG, GIGI GEORGIANA is one of the individuals responsible for the current prosecution. By maintaining a presence in the single art unit, the company can expect consistent application of examination guidelines for its Biotechnology & Pharmaceuticals filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, GIGI GEORGIANA | 1 | 31.8% | +30.8% |
| ISMAIL, REHANA | 1 | 75.8% | +34.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18917928 | METHOD OF TREATING DIABETIC MACULAR EDEMA | HUANG, GIGI GEORGIANA | — |
| 18792377 | MULTIDOSE OPHTHALMIC COMPOSITIONS | ISMAIL, REHANA | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18917928 | METHOD OF TREATING DIABETIC MACULAR EDEMA | HUANG, GIGI GEORGIANA | 1613 | §103DP | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18792377 | MULTIDOSE OPHTHALMIC COMPOSITIONS | ISMAIL, REHANA | — | §103DP | Non-Final OA | — | Pending | Aug 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial